• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Oct 6, 2017
Clinical News

Merck discontinues HCV candidates MK-3682B and MK-3682C

Read More
BioCentury | Oct 6, 2017
Clinical News

Merck discontinues HCV candidates MK-3682B and MK-3682C

Read More
BioCentury | Sep 29, 2017
Clinical News

Merck discontinues HCV candidates

Read More
BioCentury | Nov 18, 2016
Clinical News

MK-3682B: Additional Ph II C-CREST-1 and C-CREST-2 data

Read More
BioCentury | Nov 18, 2016
Clinical News

MK-3682B: Interim Ph II C-SURGE data

Read More
BioCentury | Nov 15, 2016
Clinical News

Merck reports HCV triple combo data

Read More
BioCentury | Apr 25, 2016
Clinical News

MK-8408: Phase I data

Read More
BioCentury | Oct 26, 2015
Clinical News

MK-8408: Interim Phase IIa data

Read More
BioCentury | Oct 26, 2015
Clinical News

Elbasvir: Interim Phase IIa data

Read More
BioCentury | Oct 26, 2015
Clinical News

Grazoprevir: Interim Phase IIa data

Read More
Items per page:
1 - 10 of 14